The Effective Statistician - in association with PSI
Today I'm talking with Rachel Tham, a principal statistician, about a book that has been incredibly impactful in both of our lives—Deep Work. We discuss what deep work is and how it can help sta...
Why are companies often running single arm studies in development?
What are the potential drawbacks and why is it not a binary choice between full comparative study and single arm tr...
Reproducible research is a key part of research in the pharma industry.
It allows for transparency, understanding, and accuracy in the research process. But how can you make your researc...
Are you a statistician working in the pharmaceutical industry and never got in touch with economic modelling and network meta-analyses? Then you should listen to this episode!
The EU HTA...
All statisticians in the Pharmaceutical Industry will be impacted by the new EU HTA regulation. Activities around HTA submissions will happen earlier than currently, in parallel to the regulator...
If you’re a statistician working in a regulatory setting, you’re probably familiar with estimands as a way to frame the clinical question of interest. But what’s the role of estimands beyond reg...
Are you a statistician, data scientist, or healthcare specialist looking for the perfect conference to attend?
The Effective Statistician Conference 2023 is an exciting opportunity ...
As a statistician, have you ever wondered—why are statistical analyses for HTA dossiers differ from those in regulatory dossiers? Aren’t they both just benefit-risk assessments? In this podcast,...
Are you curious about aggregate safety assessment planning?
Whether you’re an experienced statistician or just starting out in the field, your work increasingly demands that you apply pr...